I2CBus
Purchase of Siemens I2C components conveys the license under the Philips I2C patent to use the components in
the I2C system provided the system conforms to the I2C specifications defined by Philips.
Edition Preliminary 1998-07-27
Published by Siemens AG,
Bereich Halbleiter, Marketing-
Kommunikation, Balanstraße 73,
81541 München
©
Siemens AG 1998.
All Rights Reserved.
Attention please!
As far as patents or other rights of third parties are concerned, liability is only assumed for components, not for applications, processes
and circuits implemented within components or assemblies.
The information describes the type of component and shall not be considered as assured characteristics.
Terms of delivery and rights to change design reserved.
For questions on technology, delivery and prices please contact the Semiconductor Group Offices in Germany or the Siemens Companies
and Representatives worldwide (see address list).
Due to technical requirements components may contain dangerous substances. For information on the types in question please contact
your nearest Siemens Office, Semiconductor Group.
Siemens AG is an approved CECC manufacturer.
Packing
Please use the recycling operators known to you. We can also help you – get in touch with your nearest sales office. By agreement we
will take packing material back, if it is sorted. You must bear the costs of transport.
For packing material that is returned to us unsorted or which we are not obliged to accept, we shall have to invoice you for any costs in-
curred.
Components used in life-support devices or systems must be expressly authorized for such purpose!
Critical components
1
of the Semiconductor Group of Siemens AG, may only be used in life-support devices or systems
2
with the express
written approval of the Semiconductor Group of Siemens AG.
1 A critical component is a component used in a life-support device or system whose failure can reasonably be expected to cause the
failure of that life-support device or system, or to affect its safety or effectiveness of that device or system.
2 Life support devices or systems are intended (a) to be implanted in the human body, or (b) to support and/or maintain and sustain hu-
man life. If they fail, it is reasonable to assume that the health of the user may be endangered.
SLx 24C32
Revision History: Current Version: Preliminary 1998-07-27
Previous Version: 02.98, 04.98
Page
(in previous
Version)
Page
(in current
Version)
Subjects (major changes since last revision)
3 3 Text was changed to “Typical programming time 5 ms for up to
32 bytes”.
11, 12 11, 13 The erase/write cycle is finished latest after 10 8ms.
21 21 The write or erase cycle is finished latest after 10 4ms.
24 24 The line “erase/write cycle” was removed.
24 24 Chapter 8.4 “Erase and Write Characteristics” has been added.